FDA Approves Drug for PET Imaging of Prostate Cancer
Approval of Gallium 68 PSMA-11 provides new imaging approach to detect prostate cancer metastasis or recurrence.
PET Imaging
Racial Disparities Seen in PET/CT Imaging for Lung Cancer
Black, Hispanic patients less likely to receive recommended imaging at time of diagnosis of NSCLC.
Image-Guided Surveillance Beneficial for Head and Neck Cancer
Similar survival seen for PET-CT-guided surveillance and planned neck dissection, but fewer operations.
PET Imaging Promising for Metastatic Prostate Cancer
Positron emission tomography (PET) imaging may offer a superior method of imaging for metastatic prostate cancer.
PET Can Guide Subsequent Treatment in Advanced Stage Hodgkin Lymphoma
PET deemed safe for use after two cycles of BEACOPPesc chemotherapy for advanced stage Hodgkin lymphoma, according to a recent study.
PET scan use for NSCLC varies by demographic subgroup
From 1998 to 2007, more PET scans for married, non-black, <80-year-old patients with lung cancer were performed.
21st Century Breast Imaging
Advances in imaging for breast cancer screening, diagnosis, and response assessment are more promising now than ever before.
PET more sensitive than CT for Merkel cell carcinoma
F-18-FDG PET more sensitive, equally specific to CT for assessing regional lymph node involvement.
PET imaging may help predict survival in cancer patients
Doctors may be able to use pretreatment PET imaging to better fight aggressive cancers, according to a study presented at the 2010 Multidisciplinary Head and Neck Cancer Symposium in Chandler, Arizona.
- Loading...
Loading...
Loading... 
Loading...